Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1007/s11886-020-01292-3

http://scihub22266oqcxt.onion/10.1007/s11886-020-01292-3
suck pdf from google scholar
32318865!7171437!32318865
unlimited free pdf from europmc32318865    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32318865  :  Publisher

suck abstract from ncbi

pmid32318865
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response #MMPMID32318865
  • Zhu H; Rhee JW; Cheng P; Waliany S; Chang A; Witteles RM; Maecker H; Davis MM; Nguyen PK; Wu SM
  • Curr Cardiol Rep 2020[Apr]; 22 (5): 32 PMID32318865show ga
  • PURPOSE OF REVIEW: Coronavirus disease of 2019 (COVID-19) is a cause of significant morbidity and mortality worldwide. While cardiac injury has been demonstrated in critically ill COVID-19 patients, the mechanism of injury remains unclear. Here, we review our current knowledge of the biology of SARS-CoV-2 and the potential mechanisms of myocardial injury due to viral toxicities and host immune responses. RECENT FINDINGS: A number of studies have reported an epidemiological association between history of cardiac disease and worsened outcome during COVID infection. Development of new onset myocardial injury during COVID-19 also increases mortality. While limited data exist, potential mechanisms of cardiac injury include direct viral entry through the angiotensin-converting enzyme 2 (ACE2) receptor and toxicity in host cells, hypoxia-related myocyte injury, and immune-mediated cytokine release syndrome. Potential treatments for reducing viral infection and excessive immune responses are also discussed. COVID patients with cardiac disease history or acquire new cardiac injury are at an increased risk for in-hospital morbidity and mortality. More studies are needed to address the mechanism of cardiotoxicity and the treatments that can minimize permanent damage to the cardiovascular system.
  • |Animals[MESH]
  • |Betacoronavirus[MESH]
  • |Coronavirus Infections/*complications/*immunology/therapy[MESH]
  • |Cytokines/immunology[MESH]
  • |Heart Diseases/*complications/*immunology/*virology[MESH]
  • |Humans[MESH]
  • |Hypoxia/pathology[MESH]
  • |Myocytes, Cardiac/pathology[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Pneumonia, Viral/*complications/*immunology/therapy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    32 5.22 2020